On September 23rd, the 2022 Sina Finance overseas Investment Summit, which Sina Finance made great efforts to create, opened grandly. Chen Jiaxian, chief representative of North China and Northeast China of the Hong Kong Trade Development Council, said that in terms of biomedicine, Hong Kong has become the largest biotechnology financing center in Asia and the second largest in the world. As of the end of March 2021, a total of 63 health and biotechnology companies have been listed on Hong Kong Exchanges and Clearing in the past three years, with a financing quota of close to HK $200 billion.
香港贸易发展局陈嘉贤：香港已成为全球第二大生物科技融资中心
Hong Kong trade development council Chan ka-yin: Hong Kong has become the second largest biotechnology financing centre in the world
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.